Park Ridge, IL, United States of America

Barbara E Hasz


Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 6(Granted Patents)


Company Filing History:


Years Active: 1992

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Barbara E. Hasz

Introduction

Barbara E. Hasz, an accomplished inventor based in Park Ridge, IL, has made significant strides in the field of immunoassays. With a focus on the development of haptens and antibodies, her work aims to enhance medical diagnostics, particularly for substances such as cotinine.

Latest Patents

Barbara E. Hasz holds a notable patent regarding haptens, tracers, immunogens, and antibodies designed for immunoassays. This patent presents a substantially optically pure hapten that is critical in immunoassays aimed at detecting cotinine. The invention details a specific structural formula where the hapten comprises a divalent radical covalently bonded to a pyridyl ring. The innovative aspects of her patent extend to the development of immunogens and antibodies derived from this hapten, as well as a fluorescent tracer relevant for immunoassays. The patent also outlines an improved immunoassay method for determining cotinine levels in biological samples.

Career Highlights

Barbara has been a part of Abbott Laboratories Corporation, where she has harnessed her skills in the field of immunology and diagnostics. This environment has provided her the opportunity to contribute meaningful advancements to medical science, underscoring her role as a leading figure in her industry.

Collaborations

Throughout her career, Barbara has worked alongside esteemed colleagues such as John A. Walling and Hsiang-Yun Y. Hu. Their collaborative efforts have further enhanced her research and innovations, showcasing the importance of teamwork in scientific discovery and development.

Conclusion

In conclusion, Barbara E. Hasz exemplifies the dedication and ingenuity of modern inventors. Her contributions to immunoassay technology not only aim to improve diagnostic practices but also highlight the ongoing innovations in the medical field. As she continues her work with Abbott Laboratories Corporation, her impact on health sciences will undoubtedly inspire future advancements.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…